الصفحة الرئيسية>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>D-Tetrahydropalmatine

D-Tetrahydropalmatine (Synonyms: (+)-Corydalis B, (+)-Tetrahydropalmatine, (R)-Tetrahydropalmatine, D-THP)

رقم الكتالوجGC38228

D-Tetrahydropalmatine هو قلويد isoquinoline ، وخاصة في جنس Corydalis

Products are for research use only. Not for human use. We do not sell to patients.

D-Tetrahydropalmatine التركيب الكيميائي

Cas No.: 3520-14-7

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
92٫00
متوفر
1mg
32٫00
متوفر
5mg
83٫00
متوفر
10mg
141٫00
متوفر
20mg
240٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-Tetrahydropalmatine is an isoquinoline alkaloid, mainly in the genus Corydalis[1]. D-Tetrahydropalmatine is a Dopamine (DA) receptor antagonist with preferential affinity toward the D1 receptors[2]. D-Tetrahydropalmatine is a potent organic cation transporter 1 (OCT1) inhibitor[3].

[1]. Ma ZJ, et al. [Effects of different types and standard of processing vinegaron inherent constituents in rhizoma of Corydalis yanhusuo]. Zhongguo Zhong Yao Za Zhi. 2006 Mar;31(6):465-7. [2]. Xu SX, et al. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xue Bao. 1989 Mar;10(2):104-10. [3]. Tu M, et al. Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important rolein its hepatotoxicity. Toxicology. 2013 Sep 15;311(3):225-30.

مراجعات

Review for D-Tetrahydropalmatine

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-Tetrahydropalmatine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.